Huapont Life Sciences Co Ltd (002004) — Capital Reinvestment Ratio
Huapont Life Sciences Co Ltd (002004) has a Capital Reinvestment Ratio of 0.25x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥635.17 Million) in capital expenditures (CN¥160.05 Million). See debt-free asset ratio of Huapont Life Sciences Co Ltd to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Huapont Life Sciences Co Ltd Capital Reinvestment Ratio (2002–2025)
This chart tracks Huapont Life Sciences Co Ltd's Capital Reinvestment Ratio across 24 annual periods. Check Huapont Life Sciences Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Huapont Life Sciences Co Ltd (2002–2025)
Year-by-year Capital Reinvestment Ratio for Huapont Life Sciences Co Ltd from 2002 to 2025. For live market cap and broader valuation context, see Huapont Life Sciences Co Ltd (002004) total market value.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.30x | CN¥2.10 Billion | CN¥638.28 Million | ▼ -48.2% |
| 2024 | 0.59x | CN¥1.63 Billion | CN¥956.27 Million | ▼ -27.2% |
| 2023 | 0.81x | CN¥1.59 Billion | CN¥1.28 Billion | ▲ +72.0% |
| 2022 | 0.47x | CN¥2.41 Billion | CN¥1.13 Billion | ▼ -52.5% |
| 2021 | 0.99x | CN¥1.27 Billion | CN¥1.26 Billion | ▲ +90.7% |
| 2020 | 0.52x | CN¥2.37 Billion | CN¥1.23 Billion | ▼ -24.6% |
| 2019 | 0.69x | CN¥2.08 Billion | CN¥1.43 Billion | ▲ +19.5% |
| 2018 | 0.58x | CN¥1.91 Billion | CN¥1.10 Billion | ▼ -65.0% |
| 2017 | 1.64x | CN¥591.40 Million | CN¥972.67 Million | ▲ +29.3% |
| 2016 | 1.27x | CN¥511.90 Million | CN¥651.24 Million | ▼ -47.6% |
| 2015 | 2.43x | CN¥342.45 Million | CN¥831.76 Million | ▲ +89.1% |
| 2014 | 1.28x | CN¥455.96 Million | CN¥585.54 Million | ▲ +18.2% |
| 2013 | 1.09x | CN¥349.51 Million | CN¥379.81 Million | ▼ -11.1% |
| 2012 | 1.22x | CN¥257.75 Million | CN¥315.21 Million | ▲ +72.7% |
| 2011 | 0.71x | CN¥135.23 Million | CN¥95.77 Million | ▼ -0.6% |
| 2010 | 0.71x | CN¥79.84 Million | CN¥56.87 Million | ▲ +19.8% |
| 2009 | 0.59x | CN¥123.53 Million | CN¥73.46 Million | ▼ -26.9% |
| 2008 | 0.81x | CN¥113.76 Million | CN¥92.49 Million | ▼ -48.1% |
| 2007 | 1.57x | CN¥79.21 Million | CN¥124.02 Million | ▲ +116.7% |
| 2006 | 0.72x | CN¥66.10 Million | CN¥47.76 Million | ▼ -28.9% |
| 2005 | 1.02x | CN¥43.69 Million | CN¥44.42 Million | ▲ +167.6% |
| 2004 | 0.38x | CN¥70.60 Million | CN¥26.83 Million | ▼ -30.1% |
| 2003 | 0.54x | CN¥56.68 Million | CN¥30.82 Million | ▼ -62.0% |
| 2002 | 1.43x | CN¥36.88 Million | CN¥52.71 Million | — |